These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3497773)

  • 1. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
    J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR
    J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
    Nemerow GR; Siaw MF; Cooper NR
    J Virol; 1986 May; 58(2):709-12. PubMed ID: 2422399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.
    Frade R; Barel M; Ehlin-Henriksson B; Klein G
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1490-3. PubMed ID: 2983347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
    Weis JJ; Richards SA; Smith JA; Fearon DT
    J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C; Cooper NR; Nemerow GR
    J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M; Fiandino A; Lyamani F; Frade R
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3.
    Vĕtvicka V; Reed W; Hoover ML; Ross GD
    J Immunol; 1993 May; 150(9):4052-60. PubMed ID: 8473749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF; Nemerow GR; Cooper NR
    J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC; Myones BL; Frazier B; Holers VM
    J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OKB7, a monoclonal antibody that reacts at or near the C3d binding site of human CR2.
    Rao PE; Wright SD; Westberg EF; Goldstein G
    Cell Immunol; 1985 Jul; 93(2):549-55. PubMed ID: 3159485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.